Generative AI for Drug Discovery
Revolutionizing Molecule Design with AI
Makya, the first generative AI platform designed by chemists for chemists, streamlines drug discovery by creating diverse, novel, and medchem-like molecules that rapidly converge towards drug candidates.
Easy-to-use interface powered by AI
Makya Generative AI SaaS platform generates molecules for your drug discovery project, via an easy to use interface made by chemists for chemists.
Diverse, Novel & Medchem-like molecules, on demand
Makya ensures the generation of truly novel molecules by incorporating Target Product Profile constraints from the start, enabling rapid convergence towards viable drug candidates.
Synthetic accessibility by design
By leveraging commercial building blocks and organic reactions, Makya allows you to put synthesis constraints at the heart of the generation process.
How it works
Iktos’s generative AI platform, has mastered organic synthetic chemistry. Trained on millions of reactions, it explores a huge chemical space (1027) to design novel molecules with optimized properties, faster.
Import your project data & define your Target Product Profile
- 3D Ligand-based & Structure-based modeling
- SAR modeling
- ADMET properties
Explore the infinite possibilities offered by Generative AI
- Growing
- Linking
- Cyclization
- Macrocyclization
- Fine tuning
Select ideal and optimized compounds, using all the scores
A unique Generative AI for de novo drug design
Explore how Makya can accelerate your de novo drug design process.
Converge Faster
Acceleration of convergence to a drug candidate.
Multi-Parametric Optimization
Generation of high value molecules based on multi parametric optimization.
Retrosynthesis inside
Focus on synthetic accessibility, ensuring you can send your compounds to synthesis.
Friendly User Interface
Empower Medicinal chemist, and facilitate Medchem & Compchem collaboration.
API
Connection of external models and scoring functions via API for enhanced flexibility.
Real-world Success with Makya
Discover how Makya has transformed drug discovery projects for our partners, delivering faster and more efficient results.
why iktos
Leading the Way in AI-Driven Drug Discovery
Proven Track Record
Over 60 successful collaborations with leading pharmaceutical, biotech, and academic institutions.
Broad Experience
Expertise across various target families and therapeutic areas, from hit discovery to lead optimization.
Expert Team
A highly skilled team specializing in AI-driven drug design, delivering innovative solutions and valuable results.
Our in-house Pipeline
Our in-house pipeline showcases our capability to apply our AI and robotics technology across various stages of drug development, from target identification to preclinical candidate.
Partner with Iktos
Embark with us
Since our inception in 2016, we have consistently delivered value through over 60+ collaborations with leading pharmaceutical, biotech, and academic institutions. Our highly skilled team is dedicated to pushing the boundaries of AI-driven drug design, making us a trusted partner in your molecular odyssey.
Get Started Today
Explore how Iktos’s groundbreaking solutions can accelerate your drug discovery projects. Contact us to learn more and request a demo of our platforms.
